Pinprick diagnostics

Eduardo Vilar () and Josep Tabernero ()
Additional contact information
Eduardo Vilar: the University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Josep Tabernero: Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.

Nature, 2012, vol. 486, issue 7404, 482-483

Abstract: Rare tumour cells with mutations that confer drug resistance can go undetected by standard testing procedures, according to two studies, which show that such mutations can be detected in patients' blood. See Letters p.532 and p.537

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/486482a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:486:y:2012:i:7404:d:10.1038_486482a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/486482a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().